通过对我国药品上市后再评价工作现状的阐述,分析我国现阶段开展再评价工作所面临的问题并提出相关建议,为完善再评价工作提供参考。
On the basis of expounding the situation of drug post-marketed reassessment,the problems of reassessment status have been analyzed.And relevant suggestions have been provided for improving drug post-marketed reassessment.